These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 37108514)
1. Design, Synthesis and Cytotoxic Activity of Novel Salicylaldehyde Hydrazones against Leukemia and Breast Cancer. Nikolova-Mladenova B; Momekov G; Zhivkova Z; Doytchinova I Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108514 [TBL] [Abstract][Full Text] [Related]
2. Hydrazide-hydrazones as Small Molecule Tropomyosin Receptor Kina se A (TRKA) Inhibitors: Synthesis, Anticancer Activities, Alam MS; Lee DU Med Chem; 2022; 19(1):47-63. PubMed ID: 35490310 [TBL] [Abstract][Full Text] [Related]
4. Antiproliferative Activity of 8-methoxy Ciprofloxacin-Hydrozone/Acylhydrazone Scaffolds. Wang LP; Xu Z; Deng GY; Xu SL Curr Top Med Chem; 2020; 20(21):1911-1915. PubMed ID: 32493190 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, in vitro anticancer activity and in silico studies of certain isoxazole-based carboxamides, ureates, and hydrazones as potential inhibitors of VEGFR2. Abou-Seri SM; Eissa AAM; Behery MGM; Omar FA Bioorg Chem; 2021 Nov; 116():105334. PubMed ID: 34534755 [TBL] [Abstract][Full Text] [Related]
6. Thieno[2,3-d]pyrimidin-4(3H)-one Derivatives of Benzimidazole as Potential Anti- Breast Cancer (MDA-MB-231, MCF-7) Agents. Dimov S; Mavrova AT; Yancheva D; Nikolova B; Tsoneva I Anticancer Agents Med Chem; 2021; 21(11):1441-1450. PubMed ID: 32698751 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, biological evaluation, drug-likeness, and in silico screening of novel benzylidene-hydrazone analogues as small molecule anticancer agents. Alam MS; Lee DU Arch Pharm Res; 2016 Feb; 39(2):191-201. PubMed ID: 26694484 [TBL] [Abstract][Full Text] [Related]
8. Biological Activity, Apoptotic Induction and Cell Cycle Arrest of New Hydrazonoyl Halides Derivatives. Mohamed MF; Hassaneen HM; Elzayat EM; El-Hallouty SM; El-Manawaty M; Saleh FM; Mohamed Y; El-Zohiry D; Fahmy G; Abdelaal N; Hassanin N; Hossam N Anticancer Agents Med Chem; 2019; 19(9):1141-1149. PubMed ID: 30843494 [TBL] [Abstract][Full Text] [Related]
9. Anticancer SAR models for MCF-7 and MDA-MB-231 breast cell lines. Qamar S; Carrasquer CA; Cunningham SL; Cunningham AR Anticancer Res; 2011 Oct; 31(10):3247-52. PubMed ID: 21965732 [TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and biologic evaluation of novel chrysin derivatives as cytotoxic agents and caspase-3/7 activators. Al-Oudat BA; Alqudah MA; Audat SA; Al-Balas QA; El-Elimat T; Hassan MA; Frhat IN; Azaizeh MM Drug Des Devel Ther; 2019; 13():423-433. PubMed ID: 30774307 [TBL] [Abstract][Full Text] [Related]
11. Anticancer phytochemical analogs 37: synthesis, characterization, molecular docking and cytotoxicity of novel plumbagin hydrazones against breast cancer cells. Dandawate P; Ahmad A; Deshpande J; Swamy KV; Khan EM; Khetmalas M; Padhye S; Sarkar F Bioorg Med Chem Lett; 2014 Jul; 24(13):2900-4. PubMed ID: 24835626 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and Evaluation of Novel Metacetamol Derivatives with Hydrazone Moiety as Anticancer and Antimicrobial Agents. Şenkardeş S; Atlıhan İ; Çayır E; Mega Tiber P; Orun O; Nigiz Ş; Özkul C; Gündüz MG; Küçükgüzel ŞG Chem Biodivers; 2023 Aug; 20(8):e202300766. PubMed ID: 37417710 [TBL] [Abstract][Full Text] [Related]
13. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells. Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057 [TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, molecular docking, in silico ADMET profile and anticancer evaluations of sulfonamide endowed with hydrazone-coupled derivatives as VEGFR-2 inhibitors. Sayed AM; Taher FA; Abdel-Samad MRK; El-Gaby MSA; El-Adl K; Saleh NM Bioorg Chem; 2021 Mar; 108():104669. PubMed ID: 33515863 [TBL] [Abstract][Full Text] [Related]
15. Design, Synthesis, Anti-Proliferative, Anti-microbial, Anti-Angiogenic Activity and Ünver H; Berber B; Demirel R; Koparal AT Anticancer Agents Med Chem; 2019; 19(13):1658-1669. PubMed ID: 30887930 [TBL] [Abstract][Full Text] [Related]
16. Novel Hydrazone Derivatives of 3-Bromopyruvate: Synthesis, Evaluation of the Cytotoxic Effects, Molecular Docking and ADME Studies. Beygi F; Mostoufi A; Mojaddami A Chem Biodivers; 2022 Jun; 19(6):e202100754. PubMed ID: 35427437 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and anticancer activity of (E)-2-benzothiazole hydrazones. Lindgren EB; de Brito MA; Vasconcelos TR; de Moraes MO; Montenegro RC; Yoneda JD; Leal KZ Eur J Med Chem; 2014 Oct; 86():12-6. PubMed ID: 25147145 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and Evaluation of 2-Naphthaleno trans-Stilbenes and Cyanostilbenes as Anticancer Agents. Madadi NR; Penthala NR; Ketkar A; Eoff RL; Trujullo-Alonso V; Guzman ML; Crooks PA Anticancer Agents Med Chem; 2018; 18(4):556-564. PubMed ID: 28403783 [TBL] [Abstract][Full Text] [Related]
19. A New Series of Antileukemic Agents: Design, Synthesis, In Vitro and In Silico Evaluation of Thiazole-Based ABL1 Kinase Inhibitors. Zeytün E; Altıntop MD; Sever B; Özdemir A; Ellakwa DE; Ocak Z; Ciftci HI; Otsuka M; Fujita M; Radwan MO Anticancer Agents Med Chem; 2021; 21(9):1099-1109. PubMed ID: 32838725 [TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and anticancer activities of diaryl urea derivatives bearing N-acylhydrazone moiety. Zhang B; Zhao Y; Zhai X; Wang L; Yang J; Tan Z; Gong P Chem Pharm Bull (Tokyo); 2012; 60(8):1046-54. PubMed ID: 22863709 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]